Lantheus Holdings Long Term Debt 2013-2025 | LNTH
Lantheus Holdings long term debt from 2013 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- Lantheus Holdings long term debt for the quarter ending March 31, 2025 was $0.566B, a 0.65% increase year-over-year.
- Lantheus Holdings long term debt for 2024 was $0.565B, a 0.64% increase from 2023.
- Lantheus Holdings long term debt for 2023 was $0.562B, a 0.71% increase from 2022.
- Lantheus Holdings long term debt for 2022 was $0.558B, a 241.9% increase from 2021.
| Lantheus Holdings Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $565 |
| 2023 | $562 |
| 2022 | $558 |
| 2021 | $163 |
| 2020 | $198 |
| 2019 | $184 |
| 2018 | $264 |
| 2017 | $265 |
| 2016 | $274 |
| 2015 | $350 |
| 2014 | $393 |
| 2013 | $399 |
| 2012 | $0 |
| Lantheus Holdings Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-03-31 | $566 |
| 2024-12-31 | $565 |
| 2024-09-30 | $1 |
| 2024-06-30 | $563 |
| 2024-03-31 | $562 |
| 2023-12-31 | $562 |
| 2023-09-30 | $561 |
| 2023-06-30 | $559 |
| 2023-03-31 | $559 |
| 2022-12-31 | $558 |
| 2022-09-30 | $152 |
| 2022-06-30 | $156 |
| 2022-03-31 | $159 |
| 2021-12-31 | $163 |
| 2021-09-30 | $167 |
| 2021-06-30 | $169 |
| 2021-03-31 | $171 |
| 2020-12-31 | $198 |
| 2020-09-30 | $205 |
| 2020-06-30 | $210 |
| 2020-03-31 | $181 |
| 2019-12-31 | $184 |
| 2019-09-30 | $186 |
| 2019-06-30 | $189 |
| 2019-03-31 | $263 |
| 2018-12-31 | $264 |
| 2018-09-30 | $264 |
| 2018-06-30 | $265 |
| 2018-03-31 | $265 |
| 2017-12-31 | $265 |
| 2017-09-30 | $266 |
| 2017-06-30 | $266 |
| 2017-03-31 | $266 |
| 2016-12-31 | $274 |
| 2016-09-30 | $295 |
| 2016-06-30 | $349 |
| 2016-03-31 | $349 |
| 2015-12-31 | $350 |
| 2015-09-30 | $350 |
| 2015-06-30 | $351 |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2014-06-30 | |
| 2013-12-31 | $399 |
| 2012-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $5.375B | $1.534B |
| Lantheus Holdings, Inc. is involved in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products for diagnosis of cardiovascular and other diseases. It serves to hospitals, clinics, group practices, integrated delivery networks, group purchasing organizations, radiopharmacies and wholesalers. Lantheus Holdings, Inc. is based in NORTH BILLERICA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.634B | 27.97 |
| Boston Scientific (BSX) | United States | $152.531B | 38.19 |
| Stryker (SYK) | United States | $145.427B | 30.41 |
| EssilorLuxottica (ESLOY) | France | $127.535B | 0.00 |
| Medtronic (MDT) | Ireland | $109.709B | 15.55 |
| Haleon (HLN) | United Kingdom | $49.754B | 28.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.468B | 0.00 |
| ResMed (RMD) | United States | $36.224B | 27.21 |
| GE HealthCare Technologies (GEHC) | United States | $32.583B | 15.47 |
| Agilent Technologies (A) | United States | $32.148B | 20.88 |
| Terumo (TRUMY) | Japan | $26.857B | 34.88 |
| Insulet (PODD) | United States | $22.748B | 89.29 |
| Koninklijke Philips (PHG) | Netherlands | $21.431B | 15.40 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.172B | 11.67 |
| Baxter (BAX) | United States | $15.441B | 11.53 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.754B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.002B | 20.89 |
| Prestige Consumer Healthcare (PBH) | United States | $4.194B | 18.74 |
| Perrigo (PRGO) | Ireland | $3.646B | 9.24 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.346B | 15.24 |
| ICU Medical (ICUI) | United States | $3.213B | 23.69 |
| Envista Holdings (NVST) | United States | $3.174B | 26.38 |
| GN Store Nord (GNNDY) | Denmark | $2.155B | 17.85 |
| QuidelOrtho (QDEL) | United States | $2.048B | 14.09 |
| LeMaitre Vascular (LMAT) | United States | $1.872B | 41.85 |
| AtriCure (ATRC) | United States | $1.719B | 0.00 |
| Neogen (NEOG) | United States | $1.302B | 16.67 |
| Acuren (TIC) | United States | $1.300B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.196B | 12.14 |
| Green Thumb Industries (GTBIF) | United States | $1.110B | 24.97 |
| BioLife Solutions (BLFS) | United States | $1.016B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.008B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.986B | 12.60 |
| InMode (INMD) | Israel | $0.930B | 9.37 |
| Evolus (EOLS) | United States | $0.642B | 0.00 |
| CeriBell (CBLL) | United States | $0.612B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.544B | 0.00 |
| Valneva SE (VALN) | France | $0.519B | 0.00 |
| Owens & Minor (OMI) | United States | $0.517B | 4.29 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Surmodics (SRDX) | United States | $0.422B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.336B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.326B | 11.98 |
| Aurora Cannabis (ACB) | Canada | $0.302B | 53.70 |
| Cresco Labs (CRLBF) | United States | $0.277B | 0.00 |
| Cerus (CERS) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.268B | 22.63 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.75 |
| Sanuwave Health (SNWV) | United States | $0.242B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.211B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.46 |
| Brainsway (BWAY) | Israel | $0.192B | 50.95 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Omeros (OMER) | United States | $0.184B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.81 |
| Organigram Global (OGI) | Canada | $0.178B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.139B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 16.58 |
| Jin Medical (ZJYL) | China | $0.122B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.62 |
| Agape ATP (ATPC) | $0.081B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.062B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Nephros (NEPH) | United States | $0.035B | 46.71 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |